RankingsPricing
  1. US-listed companies
  2. WEST PHARMACEUTICAL SERVICES INC
  3. Financials
  4. Cost of revenue

WEST PHARMACEUTICAL SERVICES INCWST

Market cap
$19.5B
P/E ratio
SummaryFinancials
Period EndCost of revenue (Million USD)YoY (%)
Dec 31, 20241,895+4.07%
Dec 31, 20231,821+3.99%
Dec 31, 20221,751+5.73%
Dec 31, 20211,656+20.06%
Dec 31, 20201,379+11.74%
Dec 31, 20191,234+5.31%
Dec 31, 20181,172+7.87%
Dec 31, 20171,087+7.79%
Dec 31, 20161,008+6.78%
Dec 31, 2015944-3.04%
Dec 31, 2014974+4.27%
Dec 31, 2013934+6.26%
Dec 31, 2012879+11.71%
Dec 31, 2010787

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)